Personalized whole-genome-based ctDNA dynamics during neoadjuvant therapy across breast cancer subtypes: results from MONITOR-Breast.
Saved in:
| Title: | Personalized whole-genome-based ctDNA dynamics during neoadjuvant therapy across breast cancer subtypes: results from MONITOR-Breast. |
|---|---|
| Authors: | Foldi J; Department of Medicine, Division of Malignant Hematology and Medical Oncology, University of Pittsburgh Medical Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA., Hogan G; Research and Development, Myriad Genetics, Salt Lake City, UT, USA., Johansen Taber K; Research and Development, Myriad Genetics, Salt Lake City, UT, USA., LaBella M; Research and Development, Myriad Genetics, Salt Lake City, UT, USA., Sadler B; Research and Development, Myriad Genetics, Salt Lake City, UT, USA., Patel R; Research and Development, Myriad Genetics, Salt Lake City, UT, USA., Balic M; Department of Medicine, Division of Malignant Hematology and Medical Oncology, University of Pittsburgh Medical Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA., Haslem D; Oncology Service Line, Intermountain Healthcare, Saint George, UT, USA., Mazo Canola M; Division of Hematology and Oncology, Mays Cancer Center, University of Texas at San Antonio, San Antonio, TX, USA., Peih-Ying Tsai J; Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH, USA., Cusick T; Department of Surgery, Ascension Via Christi Hospitals Wichita, Inc.., Wichita, KS, USA., Nathwani N; Carolina Blood and Cancer Care Associates, Lancaster, SC, USA., Naito Y; Department of Medical Oncology, Department of General Internal Medicine, Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan., Funasaka C; Department of Medical Oncology, Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan., Wong K; Department of Medical Oncology, Providence Saint Joseph's Medical Center, Burbank, CA, USA., Ham A; Research and Development, Myriad Genetics, Salt Lake City, UT, USA., Acevedo A; Research and Development, Myriad Genetics, Salt Lake City, UT, USA., Battey CJ; Research and Development, Myriad Genetics, Salt Lake City, UT, USA., Gould GM; Research and Development, Myriad Genetics, Salt Lake City, UT, USA., Muzzey D; Research and Development, Myriad Genetics, Salt Lake City, UT, USA., Jasper J; Research and Development, Myriad Genetics, Salt Lake City, UT, USA. |
| Source: | Future oncology (London, England) [Future Oncol] 2026 Jul; Vol. 22 (16), pp. 1985-1996. Date of Electronic Publication: 2026 Jun 21. |
| Publication Type: | Journal Article; Observational Study |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42324681 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Personalized whole-genome-based ctDNA dynamics during neoadjuvant therapy across breast cancer subtypes: results from MONITOR-Breast. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Foldi+J%22">Foldi J</searchLink>; Department of Medicine, Division of Malignant Hematology and Medical Oncology, University of Pittsburgh Medical Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Hogan+G%22">Hogan G</searchLink>; Research and Development, Myriad Genetics, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Johansen+Taber+K%22">Johansen Taber K</searchLink>; Research and Development, Myriad Genetics, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22LaBella+M%22">LaBella M</searchLink>; Research and Development, Myriad Genetics, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Sadler+B%22">Sadler B</searchLink>; Research and Development, Myriad Genetics, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Patel+R%22">Patel R</searchLink>; Research and Development, Myriad Genetics, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Balic+M%22">Balic M</searchLink>; Department of Medicine, Division of Malignant Hematology and Medical Oncology, University of Pittsburgh Medical Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Haslem+D%22">Haslem D</searchLink>; Oncology Service Line, Intermountain Healthcare, Saint George, UT, USA.<br /><searchLink fieldCode="AU" term="%22Mazo+Canola+M%22">Mazo Canola M</searchLink>; Division of Hematology and Oncology, Mays Cancer Center, University of Texas at San Antonio, San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Peih-Ying+Tsai+J%22">Peih-Ying Tsai J</searchLink>; Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Cusick+T%22">Cusick T</searchLink>; Department of Surgery, Ascension Via Christi Hospitals Wichita, Inc.., Wichita, KS, USA.<br /><searchLink fieldCode="AU" term="%22Nathwani+N%22">Nathwani N</searchLink>; Carolina Blood and Cancer Care Associates, Lancaster, SC, USA.<br /><searchLink fieldCode="AU" term="%22Naito+Y%22">Naito Y</searchLink>; Department of Medical Oncology, Department of General Internal Medicine, Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan.<br /><searchLink fieldCode="AU" term="%22Funasaka+C%22">Funasaka C</searchLink>; Department of Medical Oncology, Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan.<br /><searchLink fieldCode="AU" term="%22Wong+K%22">Wong K</searchLink>; Department of Medical Oncology, Providence Saint Joseph's Medical Center, Burbank, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ham+A%22">Ham A</searchLink>; Research and Development, Myriad Genetics, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Acevedo+A%22">Acevedo A</searchLink>; Research and Development, Myriad Genetics, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Battey+CJ%22">Battey CJ</searchLink>; Research and Development, Myriad Genetics, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Gould+GM%22">Gould GM</searchLink>; Research and Development, Myriad Genetics, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Muzzey+D%22">Muzzey D</searchLink>; Research and Development, Myriad Genetics, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Jasper+J%22">Jasper J</searchLink>; Research and Development, Myriad Genetics, Salt Lake City, UT, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101256629%22">Future oncology (London, England)</searchLink> [Future Oncol] 2026 Jul; Vol. 22 (16), pp. 1985-1996. <i>Date of Electronic Publication: </i>2026 Jun 21. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Observational Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101256629 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-8301 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214796694%22">14796694 </searchLink><i>NLM ISO Abbreviation: </i>Future Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42324681 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/14796694.2026.2690165 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1985 Titles: – TitleFull: Personalized whole-genome-based ctDNA dynamics during neoadjuvant therapy across breast cancer subtypes: results from MONITOR-Breast. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Foldi J – PersonEntity: Name: NameFull: Hogan G – PersonEntity: Name: NameFull: Johansen Taber K – PersonEntity: Name: NameFull: LaBella M – PersonEntity: Name: NameFull: Sadler B – PersonEntity: Name: NameFull: Patel R – PersonEntity: Name: NameFull: Balic M – PersonEntity: Name: NameFull: Haslem D – PersonEntity: Name: NameFull: Mazo Canola M – PersonEntity: Name: NameFull: Peih-Ying Tsai J – PersonEntity: Name: NameFull: Cusick T – PersonEntity: Name: NameFull: Nathwani N – PersonEntity: Name: NameFull: Naito Y – PersonEntity: Name: NameFull: Funasaka C – PersonEntity: Name: NameFull: Wong K – PersonEntity: Name: NameFull: Ham A – PersonEntity: Name: NameFull: Acevedo A – PersonEntity: Name: NameFull: Battey CJ – PersonEntity: Name: NameFull: Gould GM – PersonEntity: Name: NameFull: Muzzey D – PersonEntity: Name: NameFull: Jasper J IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2026 Jul Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1744-8301 Numbering: – Type: volume Value: 22 – Type: issue Value: 16 Titles: – TitleFull: Future oncology (London, England) Type: main |
| ResultId | 1 |